Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26028
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMoraliyage, Harsha-
dc.contributor.authorDe Silva, Daswin-
dc.contributor.authorRanasinghe, Weranja-
dc.contributor.authorAdikari, Achini-
dc.contributor.authorAlahakoon, Damminda-
dc.contributor.authorPrasad, Raj-
dc.contributor.authorLawrentschuk, Nathan-
dc.contributor.authorBolton, Damien M-
dc.date2020-11-26-
dc.date.accessioned2021-03-09T05:05:15Z-
dc.date.available2021-03-09T05:05:15Z-
dc.date.issued2021-02-
dc.identifier.citationThe Oncologist 2021; 26(2): e342-e344en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26028-
dc.description.abstractThe lockdown measures of the ongoing COVID-19 pandemic have disengaged patients with cancer from formal health care settings, leading to an increased use of social media platforms to address unmet needs and expectations. Although remote health technologies have addressed some of the medical needs, the emotional and mental well-being of these patients remain underexplored and underreported. We used a validated artificial intelligence framework to conduct a comprehensive real-time analysis of two data sets of 2,469,822 tweets and 21,800 discussions by patients with cancer during this pandemic. Lung and breast cancer are most prominently discussed, and the most concerns were expressed regarding delayed diagnosis, cancellations, missed treatments, and weakened immunity. All patients expressed significant negative sentiment, with fear being the predominant emotion. Even as some lockdown measures ease, it is crucial that patients with cancer are engaged using social media platforms for real-time identification of issues and the provision of informational and emotional support.en
dc.language.isoeng
dc.titleCancer in Lockdown: Impact of the COVID-19 Pandemic on Patients with Cancer.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Oncologisten
dc.identifier.affiliationUniversity of Texas, MD Anderson Cancer, Houston, Texas, USAen
dc.identifier.affiliationSurgery (University of Melbourne)en
dc.identifier.affiliationEJ Whitten Prostate Cancer Research Centre at Epworth Healthcare, Melbourne, Australiaen
dc.identifier.affiliationDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationResearch Centre for Data Analytics and Cognition, La Trobe University, Melbourne, Australiaen
dc.identifier.affiliationNational Health Service Trust, North Bristol, England, United Kingdom..en
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen
dc.identifier.doi10.1002/onco.13604en
dc.type.contentTexten
dc.identifier.orcid0000-0002-6212-8312en
dc.identifier.pubmedid33210442
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Jun 22, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.